FY2022-2026 DTRA Chemical / Biological Technologies Broad Agency Announcement

Description

UPDATED AUGUST 30, 2024: TOPIC CALL 5, QUESTIONS & ANSWERS (Q and A_Ph II) UPDATED AUGUST 30, 2024: TOPIC CALL 4, QUESTIONS & ANSWERS (Q and A_Ph II) UPDATED JUNE 6, 2024: TOPIC CALL 5, QUESTIONS & ANSWERS (Q and A_PhI) UPDATED MAY 10, 2024: TOPIC CALL 4, QUESTIONS & ANSWERS (Q and A_Ph I) UPDATED APRIL 30, 2024: TOPIC CALL 5 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO THE TOPIC INCLUDED IN TOPIC CALL 5 IS MAY 14, 2024. THE DEADLINE TO SUBMIT A PROPOSAL FOR THE TOPIC INCLUDED IN TOPIC CALL 5 IS JUNE 25, 2024 AT 2:00PM EDT. UPDATED APRIL 1, 2024: TOPIC CALL 4 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO TOPICS INCLUDED IN TOPIC CALL 4 IS APRIL 16, 2024. THE DEADLINE TO SUBMIT A PROPOSAL FOR TOPICS INCLUDED IN TOPIC CALL 4 IS MAY 29, 2024 AT 2:00PM EDT. UPDATED SEPTEMBER 29, 2023: TOPIC CALL 3, QUESTIONS & ANSWERS (Q and A) UPDATED SEPTEMBER 6, 2023: TOPIC CALL 3 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO TOPICS INCLUDED IN TOPIC CALL 3 IS SEPTEMBER 18, 2023. THE DEADLINE TO SUBMIT A PROPOSAL FOR TOPICS INCLUDED IN TOPIC CALL 3 IS OCTOBER 26, 2023 AT 2:00PM EDT. UPDATED AUGUST 14, 2023: TOPIC CALL 2, QUESTIONS & ANSWERS (Q and A_Ph II) UPDATED APRIL 24, 2023: TOPIC CALL 2, QUESTIONS & ANSWERS (Q and A_Ph I) UPDATED MARCH 21, 2023: TOPIC CALL 2 THE DEADLINE TO SUBMIT QUESTIONS RELATED TO TOPICS INCLUDED IN TOPIC CALL 2 IS MARCH 28, 2023. THE DEADLINE TO SUBMIT A PHASE I PROPOSAL FOR TOPICS INCLUDED IN TOPIC CALL 2 IS MAY 10, 2023 AT 2:00PM EDT. UPDATED NOV 10, 2022: TOPIC CALL 1, QUESTIONS & ANSWERS (Q and A_Ph II) The purpose of this BAA is to serve as a five-year (60-month) open continuous vehicle through which topics will be released as individual calls as they become available during the BAA open period. This BAA will remain open for five years from the date of release. The scope of this BAA is limited to projects that meet Technology Readiness Level (TRL) definitions in the TRL range of 3-6 (see ATTACHMENT 1 for TRL definitions). Upon completion of the proposed development efforts, solutions should strive to meet a TRL in the range of 4-6. Proposals that address technologies at TRL 4 or greater should also be aware of the Manufacturing Readiness Level (MRL) considerations. The DTRA RD-CB mission was established by the Department of Defense (DoD) to provide state-of-the-art defense capabilities to allow military forces of the United States to operate and to successfully complete their missions in chemical and biological warfare environments. The scope of mission efforts and the priorities assigned to specific projects are influenced by changes in military and civilian Chemical and Biological Defense (CBD) science and technology, advanced developments, operational requirements, military threat assessments, and national defense strategies. To keep pace with defense capability requirements, the CBD Program (CBDP), as part of its mission, routinely promulgates chemical and biological research. The comprehensive research program encompasses both intramural and extramural sources, and the role of each is vital to the fulfillment of the CBDP objectives. DTRA is seeking optimum approaches to meet technology objectives with a goal to identify and select science and technology projects that can be transitioned to joint acquisition programs.